Skip to main content
Premium Trial:

Request an Annual Quote

Oncosis Receives $6.7M SBIR Grant

NEW YORK, Dec 12 – Oncosis said Tuesday it received a four-year, $6.7 million Small Business Innovation Research grant from the National Institutes of Health to develop its Photosis technology.

Photosis is an automated, laser-based cell treatment system that has clinical and genomic applications, the company said.

While the grant will at first be used to develop an instrument for tumor cell purging, Oncosis said that the technology could also be used for gene expression profiling and cell selection and purification.

Manfred Koller, Oncosis' vice president R&D, said in a statement that the science behind the optical scanning and laser system used in cell treatment stemmed from the government's research in the Star Wars program in the 1980s.

The technology has so far been applied to such industries as computer chip manufacturing, which require a high degree of laser speed, accuracy, and precision.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.